[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Non-Small Cell Lung Cancer Treatment (NSCLC) Market Research Report 2024(Status and Outlook)

February 2024 | 129 pages | ID: GF50E55C0894EN
Bosson Research

US$ 3,200.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Report Overview

This report provides a deep insight into the global Non-Small Cell Lung Cancer Treatment (NSCLC) market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Non-Small Cell Lung Cancer Treatment (NSCLC) Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Non-Small Cell Lung Cancer Treatment (NSCLC) market in any manner.

Global Non-Small Cell Lung Cancer Treatment (NSCLC) Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

AbbVie Inc.

Astellas Pharma

AstraZeneca

Avid Bioservices Inc.

Bayer Healthcare

Biogen Inc.

Blueprint Medicines Corp

Eli Lilly and Company

Merck & co Inc.

Novartis

Pfizer Inc.

Market Segmentation (by Type)

Angiogenesis Inhibitor

Epidermal Growth Factor Receptor Blocker

Kinase Inhibitor

Microtubule Stabilizer

Folate Antimetabolites

Others

Market Segmentation (by Application)

Adenocarcinoma

Squamous Cell Carcinoma

Large Cell Carcinoma

Geographic Segmentation
  • North America (USA, Canada, Mexico)
  • Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
  • South America (Brazil, Argentina, Columbia, Rest of South America)
  • The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
  • Industry drivers, restraints, and opportunities covered in the study
  • Neutral perspective on the market performance
  • Recent industry trends and developments
  • Competitive landscape & strategies of key players
  • Potential & niche segments and regions exhibiting promising growth covered
  • Historical, current, and projected market size, in terms of value
  • In-depth analysis of the Non-Small Cell Lung Cancer Treatment (NSCLC) Market
  • Overview of the regional outlook of the Non-Small Cell Lung Cancer Treatment (NSCLC) Market:
Key Reasons to Buy this Report:
  • Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
  • This enables you to anticipate market changes to remain ahead of your competitors
  • You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
  • The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
  • Provision of market value (USD Billion) data for each segment and sub-segment
  • Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
  • Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
  • Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
  • Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
  • The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
  • Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
  • Provides insight into the market through Value Chain
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • 6-month post-sales analyst support
Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Non-Small Cell Lung Cancer Treatment (NSCLC) Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Non-Small Cell Lung Cancer Treatment (NSCLC)
1.2 Key Market Segments
  1.2.1 Non-Small Cell Lung Cancer Treatment (NSCLC) Segment by Type
  1.2.2 Non-Small Cell Lung Cancer Treatment (NSCLC) Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 NON-SMALL CELL LUNG CANCER TREATMENT (NSCLC) MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size (M USD) Estimates and Forecasts (2019-2030)
  2.1.2 Global Non-Small Cell Lung Cancer Treatment (NSCLC) Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 NON-SMALL CELL LUNG CANCER TREATMENT (NSCLC) MARKET COMPETITIVE LANDSCAPE

3.1 Global Non-Small Cell Lung Cancer Treatment (NSCLC) Sales by Manufacturers (2019-2024)
3.2 Global Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue Market Share by Manufacturers (2019-2024)
3.3 Non-Small Cell Lung Cancer Treatment (NSCLC) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Non-Small Cell Lung Cancer Treatment (NSCLC) Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Non-Small Cell Lung Cancer Treatment (NSCLC) Sales Sites, Area Served, Product Type
3.6 Non-Small Cell Lung Cancer Treatment (NSCLC) Market Competitive Situation and Trends
  3.6.1 Non-Small Cell Lung Cancer Treatment (NSCLC) Market Concentration Rate
  3.6.2 Global 5 and 10 Largest Non-Small Cell Lung Cancer Treatment (NSCLC) Players Market Share by Revenue
  3.6.3 Mergers & Acquisitions, Expansion

4 NON-SMALL CELL LUNG CANCER TREATMENT (NSCLC) INDUSTRY CHAIN ANALYSIS

4.1 Non-Small Cell Lung Cancer Treatment (NSCLC) Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF NON-SMALL CELL LUNG CANCER TREATMENT (NSCLC) MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
  5.5.1 New Product Developments
  5.5.2 Mergers & Acquisitions
  5.5.3 Expansions
  5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies

6 NON-SMALL CELL LUNG CANCER TREATMENT (NSCLC) MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Non-Small Cell Lung Cancer Treatment (NSCLC) Sales Market Share by Type (2019-2024)
6.3 Global Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size Market Share by Type (2019-2024)
6.4 Global Non-Small Cell Lung Cancer Treatment (NSCLC) Price by Type (2019-2024)

7 NON-SMALL CELL LUNG CANCER TREATMENT (NSCLC) MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Non-Small Cell Lung Cancer Treatment (NSCLC) Market Sales by Application (2019-2024)
7.3 Global Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size (M USD) by Application (2019-2024)
7.4 Global Non-Small Cell Lung Cancer Treatment (NSCLC) Sales Growth Rate by Application (2019-2024)

8 NON-SMALL CELL LUNG CANCER TREATMENT (NSCLC) MARKET SEGMENTATION BY REGION

8.1 Global Non-Small Cell Lung Cancer Treatment (NSCLC) Sales by Region
  8.1.1 Global Non-Small Cell Lung Cancer Treatment (NSCLC) Sales by Region
  8.1.2 Global Non-Small Cell Lung Cancer Treatment (NSCLC) Sales Market Share by Region
8.2 North America
  8.2.1 North America Non-Small Cell Lung Cancer Treatment (NSCLC) Sales by Country
  8.2.2 U.S.
  8.2.3 Canada
  8.2.4 Mexico
8.3 Europe
  8.3.1 Europe Non-Small Cell Lung Cancer Treatment (NSCLC) Sales by Country
  8.3.2 Germany
  8.3.3 France
  8.3.4 U.K.
  8.3.5 Italy
  8.3.6 Russia
8.4 Asia Pacific
  8.4.1 Asia Pacific Non-Small Cell Lung Cancer Treatment (NSCLC) Sales by Region
  8.4.2 China
  8.4.3 Japan
  8.4.4 South Korea
  8.4.5 India
  8.4.6 Southeast Asia
8.5 South America
  8.5.1 South America Non-Small Cell Lung Cancer Treatment (NSCLC) Sales by Country
  8.5.2 Brazil
  8.5.3 Argentina
  8.5.4 Columbia
8.6 Middle East and Africa
  8.6.1 Middle East and Africa Non-Small Cell Lung Cancer Treatment (NSCLC) Sales by Region
  8.6.2 Saudi Arabia
  8.6.3 UAE
  8.6.4 Egypt
  8.6.5 Nigeria
  8.6.6 South Africa

9 KEY COMPANIES PROFILE

9.1 AbbVie Inc.
  9.1.1 AbbVie Inc. Non-Small Cell Lung Cancer Treatment (NSCLC) Basic Information
  9.1.2 AbbVie Inc. Non-Small Cell Lung Cancer Treatment (NSCLC) Product Overview
  9.1.3 AbbVie Inc. Non-Small Cell Lung Cancer Treatment (NSCLC) Product Market Performance
  9.1.4 AbbVie Inc. Business Overview
  9.1.5 AbbVie Inc. Non-Small Cell Lung Cancer Treatment (NSCLC) SWOT Analysis
  9.1.6 AbbVie Inc. Recent Developments
9.2 Astellas Pharma
  9.2.1 Astellas Pharma Non-Small Cell Lung Cancer Treatment (NSCLC) Basic Information
  9.2.2 Astellas Pharma Non-Small Cell Lung Cancer Treatment (NSCLC) Product Overview
  9.2.3 Astellas Pharma Non-Small Cell Lung Cancer Treatment (NSCLC) Product Market Performance
  9.2.4 Astellas Pharma Business Overview
  9.2.5 Astellas Pharma Non-Small Cell Lung Cancer Treatment (NSCLC) SWOT Analysis
  9.2.6 Astellas Pharma Recent Developments
9.3 AstraZeneca
  9.3.1 AstraZeneca Non-Small Cell Lung Cancer Treatment (NSCLC) Basic Information
  9.3.2 AstraZeneca Non-Small Cell Lung Cancer Treatment (NSCLC) Product Overview
  9.3.3 AstraZeneca Non-Small Cell Lung Cancer Treatment (NSCLC) Product Market Performance
  9.3.4 AstraZeneca Non-Small Cell Lung Cancer Treatment (NSCLC) SWOT Analysis
  9.3.5 AstraZeneca Business Overview
  9.3.6 AstraZeneca Recent Developments
9.4 Avid Bioservices Inc.
  9.4.1 Avid Bioservices Inc. Non-Small Cell Lung Cancer Treatment (NSCLC) Basic Information
  9.4.2 Avid Bioservices Inc. Non-Small Cell Lung Cancer Treatment (NSCLC) Product Overview
  9.4.3 Avid Bioservices Inc. Non-Small Cell Lung Cancer Treatment (NSCLC) Product Market Performance
  9.4.4 Avid Bioservices Inc. Business Overview
  9.4.5 Avid Bioservices Inc. Recent Developments
9.5 Bayer Healthcare
  9.5.1 Bayer Healthcare Non-Small Cell Lung Cancer Treatment (NSCLC) Basic Information
  9.5.2 Bayer Healthcare Non-Small Cell Lung Cancer Treatment (NSCLC) Product Overview
  9.5.3 Bayer Healthcare Non-Small Cell Lung Cancer Treatment (NSCLC) Product Market Performance
  9.5.4 Bayer Healthcare Business Overview
  9.5.5 Bayer Healthcare Recent Developments
9.6 Biogen Inc.
  9.6.1 Biogen Inc. Non-Small Cell Lung Cancer Treatment (NSCLC) Basic Information
  9.6.2 Biogen Inc. Non-Small Cell Lung Cancer Treatment (NSCLC) Product Overview
  9.6.3 Biogen Inc. Non-Small Cell Lung Cancer Treatment (NSCLC) Product Market Performance
  9.6.4 Biogen Inc. Business Overview
  9.6.5 Biogen Inc. Recent Developments
9.7 Blueprint Medicines Corp
  9.7.1 Blueprint Medicines Corp Non-Small Cell Lung Cancer Treatment (NSCLC) Basic Information
  9.7.2 Blueprint Medicines Corp Non-Small Cell Lung Cancer Treatment (NSCLC) Product Overview
  9.7.3 Blueprint Medicines Corp Non-Small Cell Lung Cancer Treatment (NSCLC) Product Market Performance
  9.7.4 Blueprint Medicines Corp Business Overview
  9.7.5 Blueprint Medicines Corp Recent Developments
9.8 Eli Lilly and Company
  9.8.1 Eli Lilly and Company Non-Small Cell Lung Cancer Treatment (NSCLC) Basic Information
  9.8.2 Eli Lilly and Company Non-Small Cell Lung Cancer Treatment (NSCLC) Product Overview
  9.8.3 Eli Lilly and Company Non-Small Cell Lung Cancer Treatment (NSCLC) Product Market Performance
  9.8.4 Eli Lilly and Company Business Overview
  9.8.5 Eli Lilly and Company Recent Developments
9.9 Merck and co Inc.
  9.9.1 Merck and co Inc. Non-Small Cell Lung Cancer Treatment (NSCLC) Basic Information
  9.9.2 Merck and co Inc. Non-Small Cell Lung Cancer Treatment (NSCLC) Product Overview
  9.9.3 Merck and co Inc. Non-Small Cell Lung Cancer Treatment (NSCLC) Product Market Performance
  9.9.4 Merck and co Inc. Business Overview
  9.9.5 Merck and co Inc. Recent Developments
9.10 Novartis
  9.10.1 Novartis Non-Small Cell Lung Cancer Treatment (NSCLC) Basic Information
  9.10.2 Novartis Non-Small Cell Lung Cancer Treatment (NSCLC) Product Overview
  9.10.3 Novartis Non-Small Cell Lung Cancer Treatment (NSCLC) Product Market Performance
  9.10.4 Novartis Business Overview
  9.10.5 Novartis Recent Developments
9.11 Pfizer Inc.
  9.11.1 Pfizer Inc. Non-Small Cell Lung Cancer Treatment (NSCLC) Basic Information
  9.11.2 Pfizer Inc. Non-Small Cell Lung Cancer Treatment (NSCLC) Product Overview
  9.11.3 Pfizer Inc. Non-Small Cell Lung Cancer Treatment (NSCLC) Product Market Performance
  9.11.4 Pfizer Inc. Business Overview
  9.11.5 Pfizer Inc. Recent Developments

10 NON-SMALL CELL LUNG CANCER TREATMENT (NSCLC) MARKET FORECAST BY REGION

10.1 Global Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size Forecast
10.2 Global Non-Small Cell Lung Cancer Treatment (NSCLC) Market Forecast by Region
  10.2.1 North America Market Size Forecast by Country
  10.2.2 Europe Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size Forecast by Country
  10.2.3 Asia Pacific Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size Forecast by Region
  10.2.4 South America Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size Forecast by Country
  10.2.5 Middle East and Africa Forecasted Consumption of Non-Small Cell Lung Cancer Treatment (NSCLC) by Country

11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)

11.1 Global Non-Small Cell Lung Cancer Treatment (NSCLC) Market Forecast by Type (2025-2030)
  11.1.1 Global Forecasted Sales of Non-Small Cell Lung Cancer Treatment (NSCLC) by Type (2025-2030)
  11.1.2 Global Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size Forecast by Type (2025-2030)
  11.1.3 Global Forecasted Price of Non-Small Cell Lung Cancer Treatment (NSCLC) by Type (2025-2030)
11.2 Global Non-Small Cell Lung Cancer Treatment (NSCLC) Market Forecast by Application (2025-2030)
  11.2.1 Global Non-Small Cell Lung Cancer Treatment (NSCLC) Sales (K Units) Forecast by Application
  11.2.2 Global Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size (M USD) Forecast by Application (2025-2030)

12 CONCLUSION AND KEY FINDINGS

LIST OF TABLES

Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size Comparison by Region (M USD)
Table 5. Global Non-Small Cell Lung Cancer Treatment (NSCLC) Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Non-Small Cell Lung Cancer Treatment (NSCLC) Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Small Cell Lung Cancer Treatment (NSCLC) as of 2022)
Table 10. Global Market Non-Small Cell Lung Cancer Treatment (NSCLC) Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Non-Small Cell Lung Cancer Treatment (NSCLC) Sales Sites and Area Served
Table 12. Manufacturers Non-Small Cell Lung Cancer Treatment (NSCLC) Product Type
Table 13. Global Non-Small Cell Lung Cancer Treatment (NSCLC) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Non-Small Cell Lung Cancer Treatment (NSCLC)
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Non-Small Cell Lung Cancer Treatment (NSCLC) Market Challenges
Table 22. Global Non-Small Cell Lung Cancer Treatment (NSCLC) Sales by Type (K Units)
Table 23. Global Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size by Type (M USD)
Table 24. Global Non-Small Cell Lung Cancer Treatment (NSCLC) Sales (K Units) by Type (2019-2024)
Table 25. Global Non-Small Cell Lung Cancer Treatment (NSCLC) Sales Market Share by Type (2019-2024)
Table 26. Global Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size (M USD) by Type (2019-2024)
Table 27. Global Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size Share by Type (2019-2024)
Table 28. Global Non-Small Cell Lung Cancer Treatment (NSCLC) Price (USD/Unit) by Type (2019-2024)
Table 29. Global Non-Small Cell Lung Cancer Treatment (NSCLC) Sales (K Units) by Application
Table 30. Global Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size by Application
Table 31. Global Non-Small Cell Lung Cancer Treatment (NSCLC) Sales by Application (2019-2024) & (K Units)
Table 32. Global Non-Small Cell Lung Cancer Treatment (NSCLC) Sales Market Share by Application (2019-2024)
Table 33. Global Non-Small Cell Lung Cancer Treatment (NSCLC) Sales by Application (2019-2024) & (M USD)
Table 34. Global Non-Small Cell Lung Cancer Treatment (NSCLC) Market Share by Application (2019-2024)
Table 35. Global Non-Small Cell Lung Cancer Treatment (NSCLC) Sales Growth Rate by Application (2019-2024)
Table 36. Global Non-Small Cell Lung Cancer Treatment (NSCLC) Sales by Region (2019-2024) & (K Units)
Table 37. Global Non-Small Cell Lung Cancer Treatment (NSCLC) Sales Market Share by Region (2019-2024)
Table 38. North America Non-Small Cell Lung Cancer Treatment (NSCLC) Sales by Country (2019-2024) & (K Units)
Table 39. Europe Non-Small Cell Lung Cancer Treatment (NSCLC) Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Non-Small Cell Lung Cancer Treatment (NSCLC) Sales by Region (2019-2024) & (K Units)
Table 41. South America Non-Small Cell Lung Cancer Treatment (NSCLC) Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Non-Small Cell Lung Cancer Treatment (NSCLC) Sales by Region (2019-2024) & (K Units)
Table 43. AbbVie Inc. Non-Small Cell Lung Cancer Treatment (NSCLC) Basic Information
Table 44. AbbVie Inc. Non-Small Cell Lung Cancer Treatment (NSCLC) Product Overview
Table 45. AbbVie Inc. Non-Small Cell Lung Cancer Treatment (NSCLC) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. AbbVie Inc. Business Overview
Table 47. AbbVie Inc. Non-Small Cell Lung Cancer Treatment (NSCLC) SWOT Analysis
Table 48. AbbVie Inc. Recent Developments
Table 49. Astellas Pharma Non-Small Cell Lung Cancer Treatment (NSCLC) Basic Information
Table 50. Astellas Pharma Non-Small Cell Lung Cancer Treatment (NSCLC) Product Overview
Table 51. Astellas Pharma Non-Small Cell Lung Cancer Treatment (NSCLC) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Astellas Pharma Business Overview
Table 53. Astellas Pharma Non-Small Cell Lung Cancer Treatment (NSCLC) SWOT Analysis
Table 54. Astellas Pharma Recent Developments
Table 55. AstraZeneca Non-Small Cell Lung Cancer Treatment (NSCLC) Basic Information
Table 56. AstraZeneca Non-Small Cell Lung Cancer Treatment (NSCLC) Product Overview
Table 57. AstraZeneca Non-Small Cell Lung Cancer Treatment (NSCLC) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. AstraZeneca Non-Small Cell Lung Cancer Treatment (NSCLC) SWOT Analysis
Table 59. AstraZeneca Business Overview
Table 60. AstraZeneca Recent Developments
Table 61. Avid Bioservices Inc. Non-Small Cell Lung Cancer Treatment (NSCLC) Basic Information
Table 62. Avid Bioservices Inc. Non-Small Cell Lung Cancer Treatment (NSCLC) Product Overview
Table 63. Avid Bioservices Inc. Non-Small Cell Lung Cancer Treatment (NSCLC) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Avid Bioservices Inc. Business Overview
Table 65. Avid Bioservices Inc. Recent Developments
Table 66. Bayer Healthcare Non-Small Cell Lung Cancer Treatment (NSCLC) Basic Information
Table 67. Bayer Healthcare Non-Small Cell Lung Cancer Treatment (NSCLC) Product Overview
Table 68. Bayer Healthcare Non-Small Cell Lung Cancer Treatment (NSCLC) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Bayer Healthcare Business Overview
Table 70. Bayer Healthcare Recent Developments
Table 71. Biogen Inc. Non-Small Cell Lung Cancer Treatment (NSCLC) Basic Information
Table 72. Biogen Inc. Non-Small Cell Lung Cancer Treatment (NSCLC) Product Overview
Table 73. Biogen Inc. Non-Small Cell Lung Cancer Treatment (NSCLC) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Biogen Inc. Business Overview
Table 75. Biogen Inc. Recent Developments
Table 76. Blueprint Medicines Corp Non-Small Cell Lung Cancer Treatment (NSCLC) Basic Information
Table 77. Blueprint Medicines Corp Non-Small Cell Lung Cancer Treatment (NSCLC) Product Overview
Table 78. Blueprint Medicines Corp Non-Small Cell Lung Cancer Treatment (NSCLC) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Blueprint Medicines Corp Business Overview
Table 80. Blueprint Medicines Corp Recent Developments
Table 81. Eli Lilly and Company Non-Small Cell Lung Cancer Treatment (NSCLC) Basic Information
Table 82. Eli Lilly and Company Non-Small Cell Lung Cancer Treatment (NSCLC) Product Overview
Table 83. Eli Lilly and Company Non-Small Cell Lung Cancer Treatment (NSCLC) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Eli Lilly and Company Business Overview
Table 85. Eli Lilly and Company Recent Developments
Table 86. Merck and co Inc. Non-Small Cell Lung Cancer Treatment (NSCLC) Basic Information
Table 87. Merck and co Inc. Non-Small Cell Lung Cancer Treatment (NSCLC) Product Overview
Table 88. Merck and co Inc. Non-Small Cell Lung Cancer Treatment (NSCLC) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Merck and co Inc. Business Overview
Table 90. Merck and co Inc. Recent Developments
Table 91. Novartis Non-Small Cell Lung Cancer Treatment (NSCLC) Basic Information
Table 92. Novartis Non-Small Cell Lung Cancer Treatment (NSCLC) Product Overview
Table 93. Novartis Non-Small Cell Lung Cancer Treatment (NSCLC) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Novartis Business Overview
Table 95. Novartis Recent Developments
Table 96. Pfizer Inc. Non-Small Cell Lung Cancer Treatment (NSCLC) Basic Information
Table 97. Pfizer Inc. Non-Small Cell Lung Cancer Treatment (NSCLC) Product Overview
Table 98. Pfizer Inc. Non-Small Cell Lung Cancer Treatment (NSCLC) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Pfizer Inc. Business Overview
Table 100. Pfizer Inc. Recent Developments
Table 101. Global Non-Small Cell Lung Cancer Treatment (NSCLC) Sales Forecast by Region (2025-2030) & (K Units)
Table 102. Global Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size Forecast by Region (2025-2030) & (M USD)
Table 103. North America Non-Small Cell Lung Cancer Treatment (NSCLC) Sales Forecast by Country (2025-2030) & (K Units)
Table 104. North America Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size Forecast by Country (2025-2030) & (M USD)
Table 105. Europe Non-Small Cell Lung Cancer Treatment (NSCLC) Sales Forecast by Country (2025-2030) & (K Units)
Table 106. Europe Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size Forecast by Country (2025-2030) & (M USD)
Table 107. Asia Pacific Non-Small Cell Lung Cancer Treatment (NSCLC) Sales Forecast by Region (2025-2030) & (K Units)
Table 108. Asia Pacific Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size Forecast by Region (2025-2030) & (M USD)
Table 109. South America Non-Small Cell Lung Cancer Treatment (NSCLC) Sales Forecast by Country (2025-2030) & (K Units)
Table 110. South America Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size Forecast by Country (2025-2030) & (M USD)
Table 111. Middle East and Africa Non-Small Cell Lung Cancer Treatment (NSCLC) Consumption Forecast by Country (2025-2030) & (Units)
Table 112. Middle East and Africa Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size Forecast by Country (2025-2030) & (M USD)
Table 113. Global Non-Small Cell Lung Cancer Treatment (NSCLC) Sales Forecast by Type (2025-2030) & (K Units)
Table 114. Global Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size Forecast by Type (2025-2030) & (M USD)
Table 115. Global Non-Small Cell Lung Cancer Treatment (NSCLC) Price Forecast by Type (2025-2030) & (USD/Unit)
Table 116. Global Non-Small Cell Lung Cancer Treatment (NSCLC) Sales (K Units) Forecast by Application (2025-2030)
Table 117. Global Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size Forecast by Application (2025-2030) & (M USD)

LIST OF FIGURES

Figure 1. Product Picture of Non-Small Cell Lung Cancer Treatment (NSCLC)
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size (M USD), 2019-2030
Figure 5. Global Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size (M USD) (2019-2030)
Figure 6. Global Non-Small Cell Lung Cancer Treatment (NSCLC) Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size by Country (M USD)
Figure 11. Non-Small Cell Lung Cancer Treatment (NSCLC) Sales Share by Manufacturers in 2023
Figure 12. Global Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue Share by Manufacturers in 2023
Figure 13. Non-Small Cell Lung Cancer Treatment (NSCLC) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Non-Small Cell Lung Cancer Treatment (NSCLC) Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Non-Small Cell Lung Cancer Treatment (NSCLC) Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Non-Small Cell Lung Cancer Treatment (NSCLC) Market Share by Type
Figure 18. Sales Market Share of Non-Small Cell Lung Cancer Treatment (NSCLC) by Type (2019-2024)
Figure 19. Sales Market Share of Non-Small Cell Lung Cancer Treatment (NSCLC) by Type in 2023
Figure 20. Market Size Share of Non-Small Cell Lung Cancer Treatment (NSCLC) by Type (2019-2024)
Figure 21. Market Size Market Share of Non-Small Cell Lung Cancer Treatment (NSCLC) by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Non-Small Cell Lung Cancer Treatment (NSCLC) Market Share by Application
Figure 24. Global Non-Small Cell Lung Cancer Treatment (NSCLC) Sales Market Share by Application (2019-2024)
Figure 25. Global Non-Small Cell Lung Cancer Treatment (NSCLC) Sales Market Share by Application in 2023
Figure 26. Global Non-Small Cell Lung Cancer Treatment (NSCLC) Market Share by Application (2019-2024)
Figure 27. Global Non-Small Cell Lung Cancer Treatment (NSCLC) Market Share by Application in 2023
Figure 28. Global Non-Small Cell Lung Cancer Treatment (NSCLC) Sales Growth Rate by Application (2019-2024)
Figure 29. Global Non-Small Cell Lung Cancer Treatment (NSCLC) Sales Market Share by Region (2019-2024)
Figure 30. North America Non-Small Cell Lung Cancer Treatment (NSCLC) Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Non-Small Cell Lung Cancer Treatment (NSCLC) Sales Market Share by Country in 2023
Figure 32. U.S. Non-Small Cell Lung Cancer Treatment (NSCLC) Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Non-Small Cell Lung Cancer Treatment (NSCLC) Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Non-Small Cell Lung Cancer Treatment (NSCLC) Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Non-Small Cell Lung Cancer Treatment (NSCLC) Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Non-Small Cell Lung Cancer Treatment (NSCLC) Sales Market Share by Country in 2023
Figure 37. Germany Non-Small Cell Lung Cancer Treatment (NSCLC) Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Non-Small Cell Lung Cancer Treatment (NSCLC) Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Non-Small Cell Lung Cancer Treatment (NSCLC) Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Non-Small Cell Lung Cancer Treatment (NSCLC) Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Non-Small Cell Lung Cancer Treatment (NSCLC) Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Non-Small Cell Lung Cancer Treatment (NSCLC) Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Non-Small Cell Lung Cancer Treatment (NSCLC) Sales Market Share by Region in 2023
Figure 44. China Non-Small Cell Lung Cancer Treatment (NSCLC) Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Non-Small Cell Lung Cancer Treatment (NSCLC) Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Non-Small Cell Lung Cancer Treatment (NSCLC) Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Non-Small Cell Lung Cancer Treatment (NSCLC) Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Non-Small Cell Lung Cancer Treatment (NSCLC) Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Non-Small Cell Lung Cancer Treatment (NSCLC) Sales and Growth Rate (K Units)
Figure 50. South America Non-Small Cell Lung Cancer Treatment (NSCLC) Sales Market Share by Country in 2023
Figure 51. Brazil Non-Small Cell Lung Cancer Treatment (NSCLC) Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Non-Small Cell Lung Cancer Treatment (NSCLC) Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Non-Small Cell Lung Cancer Treatment (NSCLC) Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Non-Small Cell Lung Cancer Treatment (NSCLC) Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Non-Small Cell Lung Cancer Treatment (NSCLC) Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Non-Small Cell Lung Cancer Treatment (NSCLC) Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Non-Small Cell Lung Cancer Treatment (NSCLC) Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Non-Small Cell Lung Cancer Treatment (NSCLC) Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Non-Small Cell Lung Cancer Treatment (NSCLC) Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Non-Small Cell Lung Cancer Treatment (NSCLC) Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Non-Small Cell Lung Cancer Treatment (NSCLC) Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Non-Small Cell Lung Cancer Treatment (NSCLC) Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Non-Small Cell Lung Cancer Treatment (NSCLC) Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Non-Small Cell Lung Cancer Treatment (NSCLC) Market Share Forecast by Type (2025-2030)
Figure 65. Global Non-Small Cell Lung Cancer Treatment (NSCLC) Sales Forecast by Application (2025-2030)
Figure 66. Global Non-Small Cell Lung Cancer Treatment (NSCLC) Market Share Forecast by Application (2025-2030)


More Publications